PRESS RELEASE published on 04/04/2023 at 14:45, 3 years 6 months ago The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate
PRESS RELEASE published on 03/23/2023 at 21:30, 3 years 7 months ago Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease Conference
PRESS RELEASE published on 03/16/2023 at 21:10, 3 years 7 months ago Edesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meeting
PRESS RELEASE published on 03/15/2023 at 13:10, 3 years 7 months ago Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study
PRESS RELEASE published on 02/10/2023 at 15:00, 3 years 8 months ago Edesa Biotech Reports Fiscal 1st Quarter 2023 Results
PRESS RELEASE published on 02/01/2023 at 14:15, 3 years 9 months ago Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study
PRESS RELEASE published on 01/17/2023 at 14:30, 3 years 9 months ago Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug
Published on 11/02/2026 at 23:15, 7 hours 58 minutes ago ATHA Energy Announces Issuance of Common Shares in Satisfaction of US$25 Million Convertible Debenture Interest Payment Obligations
Published on 11/02/2026 at 22:30, 8 hours 43 minutes ago Sparton Files Morrison Mine N-I 43-101 Technical Report
Published on 11/02/2026 at 17:00, 14 hours 13 minutes ago PPX Mining Initiates Operating Permit Process for Igor Processing Plant
Published on 11/02/2026 at 17:00, 14 hours 13 minutes ago QNX Launches Global Developer Hackathon with $50,000 in Prizes to Accelerate Innovation in Mission-Critical Systems
Published on 11/03/2026 at 07:05, 8 minutes ago Reju Expands Industry Network Through its Work with Six Mills
Published on 11/03/2026 at 07:05, 8 minutes ago Lonza Signs Agreement to Acquire US CDMO Network from Merck KGaA, Darmstadt, Germany, and Significantly Expands its US Presence
Published on 11/03/2026 at 07:03, 9 minutes ago Q3 2026: TeamViewer sees strong new business momentum in TeamViewer ONE and its largest Enterprise accounts as DEX turnaround progresses, full-year revenue guidance adjusted reflecting softer Q4 2026
Published on 11/03/2026 at 07:02, 10 minutes ago EQS-Adhoc: TeamViewer SE: TeamViewer SE: TeamViewer publishes Q3 2026 results and adjusts full-year revenue guidance reflecting softer Q4 2026 outlook
Published on 11/02/2026 at 18:30, 12 hours 43 minutes ago Disclosure of transactions in own shares from October 26 to October 30, 2026
Published on 11/02/2026 at 18:17, 12 hours 56 minutes ago Reporting on share buyback transactions carried out between October 28 and October 29, 2026
Published on 11/02/2026 at 18:00, 13 hours 13 minutes ago Covivio - Information on total number of voting rights and share capital
